At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2 Efficacy and Safety Study of LY2484595 Alone and in Combination With Atorvastatin, Simvastatin, and Rosuvastatin in Patients With Hypercholesterolemia or Low HDL-C
In Brief
A Phase 2 clinical trial evaluating LY2484595, Atorvastatin, and 4 other interventions for Dyslipidemia. Completed, enrolled 398 participants across 59 sites in 6 countries.
Detailed Summary
The primary purpose of your participation in this study is to help answer the following research question(s) * Whether LY2484595 in combination with a statin drug (atorvastatin, simvastatin or rosuvastatin; currently used to treat abnormal fat or cholesterol in blood) improves the blood fat profile more than statins alone. * Whether LY2484595 alone improves blood fats profile compared to sugar pills. * Whether LY2484595 interferes with break down or functioning of statins. * Whether LY2484595 has any side effects that would not support testing it in future studies.
Study Details
Timeline
Interventions
Administered daily by mouth for 12 weeks
Administered daily by mouth for 12 weeks
Administered daily by mouth for 12 weeks
Administered daily by mouth for 12 weeks
Administered daily by mouth for 12 weeks
Administered daily by mouth for 12 weeks